Advocacy at a Glance 12/8/19 Advocacy at a Glance 12/8/19 The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems Read More Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More Advocacy at a Glance 8/2/19 Advocacy at a Glance 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More Advocacy at a Glance 7/26/19 Advocacy at a Glance 7/26/19 Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21 Read More Analysis and Commentary 4/12/19 Analysis and Commentary 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More Analysis and Commentary 2/8/19 Analysis and Commentary 2/8/19 The Questions -- and the Answers -- Continue! Read More Advocacy at a Glance 10/30/15 Advocacy at a Glance 10/30/15 How Does the Budget Deal Impact FDA’s Appropriations and more Read More Uncategorized 10/28/15 Uncategorized 10/28/15 A Potential Budget Deal Is in Place Read More Analysis and Commentary 10/2/15 Analysis and Commentary 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More
Advocacy at a Glance 12/8/19 Advocacy at a Glance 12/8/19 The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems Read More
Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More
Advocacy at a Glance 8/2/19 Advocacy at a Glance 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More
Advocacy at a Glance 7/26/19 Advocacy at a Glance 7/26/19 Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21 Read More
Analysis and Commentary 4/12/19 Analysis and Commentary 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More
Analysis and Commentary 2/8/19 Analysis and Commentary 2/8/19 The Questions -- and the Answers -- Continue! Read More
Advocacy at a Glance 10/30/15 Advocacy at a Glance 10/30/15 How Does the Budget Deal Impact FDA’s Appropriations and more Read More
Analysis and Commentary 10/2/15 Analysis and Commentary 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More
